Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arsenic | 26 | 2025 | 64 | 7.940 |
Why?
|
| Environmental Exposure | 18 | 2025 | 579 | 4.370 |
Why?
|
| Water Pollutants, Chemical | 11 | 2025 | 215 | 3.720 |
Why?
|
| Uranium | 8 | 2025 | 18 | 2.520 |
Why?
|
| Lung Diseases | 4 | 2022 | 767 | 1.610 |
Why?
|
| Water Supply | 5 | 2025 | 78 | 1.590 |
Why?
|
| Atherosclerosis | 7 | 2024 | 415 | 1.500 |
Why?
|
| Oryza | 3 | 2020 | 33 | 1.460 |
Why?
|
| Cadmium | 7 | 2025 | 69 | 1.440 |
Why?
|
| Drinking Water | 7 | 2025 | 84 | 1.400 |
Why?
|
| Selenium | 3 | 2024 | 43 | 1.220 |
Why?
|
| Metals | 4 | 2025 | 136 | 1.180 |
Why?
|
| Nutrition Surveys | 5 | 2024 | 266 | 1.100 |
Why?
|
| Mercury | 2 | 2023 | 41 | 1.000 |
Why?
|
| Trihalomethanes | 1 | 2025 | 6 | 0.960 |
Why?
|
| Extracellular Vesicles | 2 | 2025 | 146 | 0.960 |
Why?
|
| California | 6 | 2025 | 431 | 0.860 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 61 | 0.860 |
Why?
|
| Indians, North American | 3 | 2024 | 643 | 0.790 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2025 | 617 | 0.750 |
Why?
|
| Lung Diseases, Obstructive | 2 | 2020 | 50 | 0.730 |
Why?
|
| MicroRNAs | 2 | 2025 | 692 | 0.700 |
Why?
|
| Dietary Exposure | 1 | 2020 | 6 | 0.690 |
Why?
|
| Edible Grain | 1 | 2020 | 49 | 0.680 |
Why?
|
| Forced Expiratory Volume | 5 | 2024 | 531 | 0.670 |
Why?
|
| Blood Pressure | 3 | 2024 | 1786 | 0.660 |
Why?
|
| School Teachers | 3 | 2024 | 23 | 0.660 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 2111 | 0.640 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2025 | 1040 | 0.640 |
Why?
|
| Middle Aged | 25 | 2025 | 33479 | 0.620 |
Why?
|
| Longitudinal Studies | 7 | 2025 | 2844 | 0.600 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 698 | 0.570 |
Why?
|
| Hypertension | 2 | 2024 | 1295 | 0.560 |
Why?
|
| Female | 35 | 2025 | 73304 | 0.540 |
Why?
|
| Prospective Studies | 14 | 2025 | 7604 | 0.510 |
Why?
|
| Cannabis | 1 | 2023 | 494 | 0.500 |
Why?
|
| Humans | 46 | 2025 | 137585 | 0.470 |
Why?
|
| Aged | 17 | 2025 | 23961 | 0.470 |
Why?
|
| Water Purification | 2 | 2016 | 152 | 0.460 |
Why?
|
| Adult | 20 | 2025 | 37929 | 0.450 |
Why?
|
| Zinc | 4 | 2024 | 297 | 0.430 |
Why?
|
| Spirometry | 4 | 2025 | 281 | 0.400 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 638 | 0.400 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1040 | 0.390 |
Why?
|
| Male | 26 | 2025 | 67762 | 0.390 |
Why?
|
| Risk Factors | 10 | 2025 | 10388 | 0.390 |
Why?
|
| United States | 13 | 2025 | 14841 | 0.380 |
Why?
|
| Bangladesh | 5 | 2019 | 56 | 0.370 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 390 | 0.360 |
Why?
|
| Biomarkers | 7 | 2025 | 4149 | 0.340 |
Why?
|
| Cohort Studies | 5 | 2025 | 5742 | 0.340 |
Why?
|
| Environmental Monitoring | 5 | 2024 | 370 | 0.340 |
Why?
|
| Public Health | 3 | 2024 | 588 | 0.330 |
Why?
|
| Cobalt | 3 | 2024 | 52 | 0.330 |
Why?
|
| DNA Methylation | 3 | 2024 | 643 | 0.320 |
Why?
|
| Vital Capacity | 3 | 2020 | 311 | 0.320 |
Why?
|
| Respiration Disorders | 2 | 2020 | 77 | 0.310 |
Why?
|
| Lead | 3 | 2024 | 64 | 0.300 |
Why?
|
| Manganese | 3 | 2024 | 62 | 0.300 |
Why?
|
| Aged, 80 and over | 6 | 2025 | 7635 | 0.300 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2253 | 0.300 |
Why?
|
| Tungsten | 2 | 2024 | 30 | 0.280 |
Why?
|
| Copper | 2 | 2024 | 104 | 0.270 |
Why?
|
| Lung | 4 | 2022 | 4060 | 0.260 |
Why?
|
| Nickel | 2 | 2024 | 62 | 0.250 |
Why?
|
| Respiratory Function Tests | 2 | 2019 | 600 | 0.240 |
Why?
|
| Halogenation | 1 | 2025 | 21 | 0.240 |
Why?
|
| Neoplasms | 1 | 2020 | 2671 | 0.240 |
Why?
|
| Butadienes | 1 | 2024 | 36 | 0.230 |
Why?
|
| Smoking | 4 | 2025 | 1627 | 0.230 |
Why?
|
| Arsenicals | 2 | 2021 | 30 | 0.220 |
Why?
|
| Trees | 1 | 2024 | 71 | 0.220 |
Why?
|
| Cities | 1 | 2024 | 133 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 101 | 0.210 |
Why?
|
| Barium | 1 | 2023 | 26 | 0.210 |
Why?
|
| Tin | 1 | 2023 | 9 | 0.210 |
Why?
|
| Trace Elements | 1 | 2024 | 51 | 0.210 |
Why?
|
| Tobacco Products | 1 | 2024 | 138 | 0.200 |
Why?
|
| Vascular Calcification | 1 | 2024 | 108 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 243 | 0.200 |
Why?
|
| Bayes Theorem | 2 | 2021 | 405 | 0.190 |
Why?
|
| Diet | 2 | 2020 | 1278 | 0.180 |
Why?
|
| Repressor Proteins | 1 | 2024 | 427 | 0.180 |
Why?
|
| Prevalence | 2 | 2025 | 2734 | 0.170 |
Why?
|
| Incidence | 3 | 2025 | 2804 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2024 | 351 | 0.170 |
Why?
|
| Vaping | 1 | 2020 | 60 | 0.160 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 35 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2021 | 159 | 0.160 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 5472 | 0.160 |
Why?
|
| Disease Progression | 2 | 2024 | 2757 | 0.150 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 103 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 279 | 0.150 |
Why?
|
| Coronary Disease | 1 | 2021 | 385 | 0.150 |
Why?
|
| Sulfones | 1 | 2019 | 110 | 0.150 |
Why?
|
| Metabolome | 1 | 2021 | 350 | 0.140 |
Why?
|
| Eating | 1 | 2020 | 380 | 0.140 |
Why?
|
| Tuberculosis | 1 | 2020 | 279 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2018 | 190 | 0.130 |
Why?
|
| Young Adult | 4 | 2025 | 13209 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 250 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2019 | 470 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 81 | 0.120 |
Why?
|
| Creatine | 1 | 2015 | 57 | 0.120 |
Why?
|
| Inhalation Exposure | 1 | 2015 | 105 | 0.110 |
Why?
|
| Family Characteristics | 1 | 2016 | 191 | 0.110 |
Why?
|
| Epidemiologic Studies | 2 | 2024 | 72 | 0.110 |
Why?
|
| Age Factors | 2 | 2025 | 3295 | 0.110 |
Why?
|
| Folic Acid | 1 | 2015 | 186 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 5778 | 0.100 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 180 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 916 | 0.100 |
Why?
|
| Heart Failure | 1 | 2025 | 2236 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1081 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 6763 | 0.080 |
Why?
|
| Cognition | 1 | 2018 | 1153 | 0.080 |
Why?
|
| Sex Factors | 1 | 2016 | 2071 | 0.080 |
Why?
|
| Water | 2 | 2023 | 460 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2526 | 0.060 |
Why?
|
| Mortality, Premature | 1 | 2025 | 14 | 0.060 |
Why?
|
| Spain | 1 | 2025 | 41 | 0.060 |
Why?
|
| Ethiopia | 1 | 2024 | 41 | 0.060 |
Why?
|
| Kenya | 1 | 2024 | 118 | 0.060 |
Why?
|
| New York City | 1 | 2024 | 85 | 0.060 |
Why?
|
| Molybdenum | 1 | 2024 | 9 | 0.050 |
Why?
|
| Forests | 1 | 2024 | 62 | 0.050 |
Why?
|
| Nitrates | 1 | 2024 | 92 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 21513 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2024 | 597 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 83 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2025 | 612 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2025 | 1266 | 0.050 |
Why?
|
| Environmental Pollution | 1 | 2021 | 20 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2024 | 451 | 0.050 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 2 | 0.050 |
Why?
|
| Research | 1 | 2024 | 451 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2024 | 739 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2020 | 117 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 316 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 1999 | 120 | 0.040 |
Why?
|
| Rifampin | 1 | 1999 | 84 | 0.040 |
Why?
|
| Wechsler Scales | 1 | 2018 | 54 | 0.040 |
Why?
|
| United States Environmental Protection Agency | 1 | 2017 | 28 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1999 | 361 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 1999 | 206 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4030 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 816 | 0.030 |
Why?
|
| Breath Tests | 1 | 2015 | 87 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1999 | 314 | 0.030 |
Why?
|
| Hospitalization | 1 | 2025 | 2199 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1389 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 230 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 2074 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6828 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 499 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 754 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 956 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2015 | 561 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 17787 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 11074 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 36940 | 0.010 |
Why?
|
| Child | 1 | 2019 | 21935 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 71 | 0.010 |
Why?
|
| Quality Control | 1 | 1999 | 172 | 0.010 |
Why?
|
| Culture Media | 1 | 1999 | 165 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 3958 | 0.000 |
Why?
|